AR031456A1 - PROTEINS THAT JOIN HCV AND ITS MEDICAL USE DIAGNOSIS AND PURIFICATION - Google Patents

PROTEINS THAT JOIN HCV AND ITS MEDICAL USE DIAGNOSIS AND PURIFICATION

Info

Publication number
AR031456A1
AR031456A1 ARP010105614A AR031456A1 AR 031456 A1 AR031456 A1 AR 031456A1 AR P010105614 A ARP010105614 A AR P010105614A AR 031456 A1 AR031456 A1 AR 031456A1
Authority
AR
Argentina
Prior art keywords
hcv
purification
proteins
join
medical use
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of AR031456A1 publication Critical patent/AR031456A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una integrina de proteínas huésped, proteína clase I de MHC y gama-glutamil transpeptidasa que son capaces de unirse a una proteína de envoltura E1 del virus de hepatitis C (HCV), y procesos para la produccion y purificacion. También se revela el uso de estas proteínas huésped en terapia y diagnostico y para composiciones y equipos de diagnostico. Además, se revela un proceso para rastrear moléculas putativas para la competencia con HCV para la union del receptor.An integrin of host proteins, MHC class I protein and gamma-glutamyl transpeptidase that are capable of binding to a hepatitis C virus (HCV) E1 envelope protein, and processes for production and purification. The use of these host proteins in therapy and diagnosis and for diagnostic compositions and equipment is also revealed. In addition, a process to track putative molecules for competition with HCV for receptor binding is revealed.

ARP010105614 2000-12-01 2001-12-03 PROTEINS THAT JOIN HCV AND ITS MEDICAL USE DIAGNOSIS AND PURIFICATION AR031456A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00870286 2000-12-01

Publications (1)

Publication Number Publication Date
AR031456A1 true AR031456A1 (en) 2003-09-24

Family

ID=8175865

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105614 AR031456A1 (en) 2000-12-01 2001-12-03 PROTEINS THAT JOIN HCV AND ITS MEDICAL USE DIAGNOSIS AND PURIFICATION

Country Status (3)

Country Link
AR (1) AR031456A1 (en)
AU (1) AU2002229581A1 (en)
WO (1) WO2002043754A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836758T2 (en) * 1997-11-06 2007-10-11 Innogenetics N.V. APO B, ANNEXIN V AND TUBULIN: MEDICAL AND DIAGNOSTIC USES AND USE FOR THE PURIFICATION OF HCV

Also Published As

Publication number Publication date
AU2002229581A1 (en) 2002-06-11
WO2002043754A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
EA200501206A1 (en) DERIVATIONS FROM SURVIVIN PEPTIDES AND THEIR APPLICATION
CY1107720T1 (en) MULTI-SYSTEM DISORDER SYNDROME VIRUS AFTER SWINE RELEASE
DK614987D0 (en) SYNTHETIC HTLV-III PEPTIDES, PREPARATIONS AND APPLICATIONS THEREOF
ATE131067T1 (en) VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) AND DIAGNOSIS.
BR0012069A (en) Compositions and methods for therapy and diagnosis of lung cancer
ES2349153T3 (en) HEPATITIS VIRUS INHIBITORS C.
AU2003228962A8 (en) Ferritin fusion proteins for use in vaccines and other applications
DE60142562D1 (en) IMMUNOSTIMULATING POLYNUCLEOTIDE SEQUENCES FOR USE IN THE SUPPRESSION OF HEPATITIS VIRUS INFECTION
AR035867A1 (en) A PARTICLE SIMILAR TO A HCV VIRUS FORMED BY A HCV WRAPPING PROTEIN, A METHOD FOR FORMING THE PARTICULATE, A MEDICINAL PRODUCT CONTAINING IT, A VACCINE, A DETECTION METHOD, A DIAGNOSTIC KIT, USE OF CEPAS OF HANS FOR THE EXPRESSION OF A HCV PROTEIN, E
EA200100509A1 (en) MODIFIED EXOSOMES AND THEIR APPLICATION
NO20052136L (en) Hepatitis C virus (HCV) vaccine.
ES2065863T3 (en) ANALYSIS FOR THE DETECTION OF VIRUSES OF HEPATITIS C.
CY1109868T1 (en) CD81 PROFESSIONAL SUBSCRIPTION PROTECTOR C
CY1105380T1 (en) PREFERRED NEURAL FILAMENT PROTEIN PORTIONS AND METHODS OF USING THEREOF
NO20082098L (en) AICA riboside formulations
BR112023024433A2 (en) ANALOGS, CONJUGATES AND METHODS OF USE OF CAMPTOTECIN
AR031456A1 (en) PROTEINS THAT JOIN HCV AND ITS MEDICAL USE DIAGNOSIS AND PURIFICATION
AR009365A1 (en) FMD VIRUS VACCINES (FMDV), PEPTIDES, DNA SEQUENCES AND THE USE OF PEPTIDES IN DETECTION SYSTEMS AND THE USE OF FMDC VACCINE FOR PREPARATION OF A COMPOSITION TO IMMUNIZE PIGS AND CATTLE
DK1287142T3 (en) A nucleic acid molecule comprising one for an SDF-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide coding nucleic acid sequence
AR004567A1 (en) METHODS TO DETECT THE T. CRUZI INFECTION, IN A BIOLOGICAL SAMPLE, A RECOMBINANT VECTOR OF EXPRESSION, A MODIFIED MICROORGANISM, A DIAGNOSTIC KIT, A PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF A MEDICINE PRODUCTION OF ANTIBODIES THAT LINK TO T. CRUZI.
DE60232155D1 (en) HUMAN RECOMBINANT ANTIBODIES TO THE HEPATITIS C (HCV) NON-STRUCTURAL NS3 PROTEIN, NUCLEIC ACID AND ITS USES
EA200401303A1 (en) MEDICINES CONTAINING STEROIDS AND NEW ANTICHOLINERGIC MEANS
ES2057579T3 (en) PEPTIDES E1 AND C OF RUBEOLA.
DK0772632T3 (en) T-cell stimulating protein of pestivirus
AR036698A1 (en) METHOD FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITHOUT TREATMENT RESPONSE

Legal Events

Date Code Title Description
FB Suspension of granting procedure